Concepedia

Anna Maria Pelizzari

AM

Statistics

Publications

8

Citations

258

H-Index

8

Active since

1998

Affiliations

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia(Current)

University of Milan

Italian Foundation of Myelodysplastic Syndromes

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

University of Florence

Anna Maria Pelizzari is an author at Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia specializing in medicine, chemotherapy, and hematologic malignancy pharmacotherapy.

Publications per year

1998–2022

8

Publications

8

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia

Valeria Santini, B Allione, Gina Zini et al. · Leukemia · 2017 · 78 citations · Full text

, , +15

Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network

Raphaël Itzykson, Valeria Santini, Sylvain Thépot et al. · Journal of Clinical Oncology · 2022 · 47 citations · Full text

, , +12

Frequency of hepatitis B virus mutant in asymptomatic hepatitis B virus carriers receiving prophylactic lamivudine during chemotherapy for hematologic malignancies

Anna Maria Pelizzari, Maddalena Motta, Elisabetta Cariani et al. · The Hematology Journal · 2004 · 31 citations

, , +17

Decitabine Versus Hydroxyurea for Advanced Proliferative CMML: Results of the Emsco Randomized Phase 3 Dacota Trial

Raphaël Itzykson, Valeria Santini, Cendrine Chaffaut et al. · Blood · 2020 · 29 citations

, , +7

Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome

Chiara Cattaneo, Doriana Gramegna, Michele Malagola et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 22 citations

, , +13

1–5 of 8